ABIONYX Pharma SA (FRA:609)
Germany flag Germany · Delayed Price · Currency is EUR
3.690
-0.090 (-2.38%)
At close: Dec 4, 2025

ABIONYX Pharma Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
1354141486824
Upgrade
Market Cap Growth
212.20%-0.54%-14.37%-28.38%178.53%229.66%
Upgrade
Enterprise Value
1363944496317
Upgrade
Last Close Price
3.841.161.231.682.570.94
Upgrade
PS Ratio
31.189.078.949.23100.22-
Upgrade
PB Ratio
24.525.495.246.766.343.66
Upgrade
P/TBV Ratio
2545.1720.0216.8328.2212.953.69
Upgrade
EV/Sales Ratio
31.358.609.459.3193.31-
Upgrade
Debt / Equity Ratio
0.750.370.430.560.460.00
Upgrade
Asset Turnover
0.300.320.300.280.04-
Upgrade
Inventory Turnover
17.3917.1621.8628.49--
Upgrade
Quick Ratio
1.301.491.681.391.862.78
Upgrade
Current Ratio
1.401.581.751.491.932.79
Upgrade
Return on Equity (ROE)
-61.53%-56.76%-46.62%-47.14%-67.28%-28.37%
Upgrade
Return on Assets (ROA)
-20.47%-19.67%-13.91%-13.64%-23.16%-18.07%
Upgrade
Return on Capital (ROIC)
-26.26%-25.86%-18.96%-19.15%-33.38%-25.58%
Upgrade
Return on Capital Employed (ROCE)
-50.90%-45.40%-31.30%-38.30%-39.50%-44.40%
Upgrade
Earnings Yield
-3.41%-10.62%-8.48%-8.68%-8.61%-7.76%
Upgrade
FCF Yield
-2.72%-8.97%-9.16%-7.27%-10.14%-2.89%
Upgrade
Buyback Yield / Dilution
-11.34%-14.80%-4.95%-12.41%-5.92%-11.21%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.